Moller-Bisgaard, S, Horslev-Petersen, K, Ejbjerg, B J, Hetland, M L, Glinatsi, D, Ornbjerg, L, Moller, J M, Boesen, M, Christensen, R, Stengaard-Pedersen, K, Madsen, O R, Jensen, B, Villadsen, J A, Hauge, E-M, Bennett, P, Hendricks, O, Asmussen, K, Kowalski, M R, Lindegaard, H, Nielsen, S M, Bliddal, H, Krogh, N S, Ellingsen, T, Nielsen, A H, Balding, L, Jurik, A G, Thomsen, H S & Ostergaard, M 2018, ' The Value of Adding MRI to a Clinical Treat-to-Target Strategy in Rheumatoid Arthritis Patients in Clinical Remission : Clinical and Radiographic Outcomes from the Imagine-RA Randomized Controlled Trial ', Annals of the Rheumatic Diseases, vol. 77, no. Suppl 2, OP0018, pp. 58-59 . < https://ard.bmj.com/content/77/Suppl_2/58.2.info > Møller-Bisgaard, S, Hørslev-Petersen, K, Ejbjerg, B J, Lund Hetland, M, Glinatsi, D, Ørnbjerg, L M, Møller, J M, Boesen, M, Christensen, R, Stengaard-Pedersen, K, Madsen, O R, Jensen, B, Villadsen, J A, Hauge, E M, Bennett, P, Hendricks, O, Asmussen, K, Kowalski, M R, Lindegaard, H M, Mai Nielsen, S, Bliddal, H, Krogh, N S, Ellingsen, T J, Nielsen, A, Balding, L, Jurik, A G, Thomsen, H S & Østergaard, M 2018, ' The Value of Adding MRI to a Clinical Treat-to-Target Strategy in Rheumatoid Arthritis Patients in Clinical Remission. Clinical and Radiographic Outcomes from the Imagine-RA Randomized Controlled Trial. ', ACR, Dallas, 11/10/2018-14/10/2018 .